- Home
- HMR vs CLNN Comparison
HMR vs CLNN Comparison
Compare HMR & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HMR
- CLNN
- Stock Information
- Founded
- HMR 1984
- CLNN 2012
- Country
- HMR Greece
- CLNN United States
- Employees
- HMR N/A
- CLNN N/A
- Industry
- HMR Marine Transportation
- CLNN Biotechnology: Pharmaceutical Preparations
- Sector
- HMR Consumer Discretionary
- CLNN Health Care
- Exchange
- HMR Nasdaq
- CLNN Nasdaq
- Market Cap
- HMR 71.1M
- CLNN 60.3M
- IPO Year
- HMR N/A
- CLNN N/A
- Fundamental
- Price
- HMR $1.30
- CLNN $8.60
- Analyst Decision
- HMR Strong Buy
- CLNN Strong Buy
- Analyst Count
- HMR 2
- CLNN 6
- Target Price
- HMR $6.00
- CLNN $32.67
- AVG Volume (30 Days)
- HMR 75.0K
- CLNN 147.0K
- Earning Date
- HMR 11-11-2025
- CLNN 11-12-2025
- Dividend Yield
- HMR N/A
- CLNN N/A
- EPS Growth
- HMR N/A
- CLNN N/A
- EPS
- HMR N/A
- CLNN N/A
- Revenue
- HMR $27,657,887.00
- CLNN $286,000.00
- Revenue This Year
- HMR $36.04
- CLNN N/A
- Revenue Next Year
- HMR $35.83
- CLNN $1,363.77
- P/E Ratio
- HMR N/A
- CLNN N/A
- Revenue Growth
- HMR N/A
- CLNN N/A
- 52 Week Low
- HMR $1.09
- CLNN $2.28
- 52 Week High
- HMR $10.04
- CLNN $11.06
- Technical
- Relative Strength Index (RSI)
- HMR N/A
- CLNN 55.61
- Support Level
- HMR N/A
- CLNN $7.66
- Resistance Level
- HMR N/A
- CLNN $8.79
- Average True Range (ATR)
- HMR 0.00
- CLNN 0.76
- MACD
- HMR 0.00
- CLNN -0.14
- Stochastic Oscillator
- HMR 0.00
- CLNN 41.67
About HMR Heidmar Maritime Holdings Corp. Common Stock
Heidmar Maritime Holdings Corp is an asset-light tanker pool, and commercial and technical management company. The company is a fast-growing tanker pool company engaged in the commercial management and chartering of crude oil and refined petroleum product tankers. The company has also recently expanded its business to offer pool management of dry bulk vessels and technical management. The company generates maximum revenue from Singapore.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.